Research Site — Zanesville, Ohio

Research Site is a clinical research site located in Zanesville, Ohio, United States 43701.

Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.

Research Site has participated in 16 clinical trials with 2 currently active.

Therapeutic areas: Relapsed or Refractory Multiple Myeloma, Acute Coronary Syndrome, Constipation-Predominant Irritable Bowel Syndrome.

Sponsors: Amgen, DalCor Pharmaceuticals, Alizyme.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Zanesville

Browse all research sites in Ohio · View every site in Zanesville

• Good Samaritan Hospital
• Genesis-Good Samaritan Hospital
• Genesis Hospital
• Genesis Healthcare System Cancer Care Center
• Genesis HealthCare System
• Pharmacotherapy Research Associates
• GSK Investigational Site
• Physicians Research, Inc
• Pfizer Investigational Site
• Physician Research, Inc.
• Forest Investigative Site 1393

Sponsor Feasibility Report

Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site?

Research Site has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site conducted?

Research Site has 16 clinical trials on record, with 2 currently active. Their work covers Relapsed or Refractory Multiple Myeloma, Acute Coronary Syndrome, Constipation-Predominant Irritable Bowel Syndrome.

Is Research Site accredited by Crixeo Clinical Trials?

Research Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.